Table 2.
Treatment characteristics
| Parameter | Study group | |
|---|---|---|
| 3D conformal radiotherapy | Volumetric modulated arc therapy | |
| Treatment regimen | ||
| Definitivea | 39 (52.0) | 14 (46.7) |
| Brachytherapya | 32 (82.1) | 10 (71.4) |
| Radiotherapy, total dose [Gy]b | 70.1 (59.4–84.4) | 69.7 (59.0–78.4) |
| Received planned dose | 39 (100.0) | 14 (100.0) |
| Postoperativea | 25 (33.3) | 6 (20.0) |
| Brachytherapy | 4 (16.0) | 0 (0.0) |
| Radiotherapy, total dose [Gy]b | 51.1 (48.6–60.4) | 50.4 (all patients) |
| Received planned dose | 24 (96.0) | 6 (100.0) |
| Preoperativea | 11 (14.7) | 10 (33.3) |
| Radiotherapy, total dose [Gy]b | 46.0 (45.0–50.4) | 45.5 (45.0–50.4) |
| Received planned dose | 11 (100.0) | 10 (100.0) |
| Chemotherapya | ||
| Yes | 56 (74.7) | 24 (80.0) |
| Received full dose | 45 (80.4) | 23 (95.8) |
| Received cisplatin | 55 (98.2) | 19 (79.2) |
aData give the number of patients; the numbers in parentheses denote the percentage
bData give the mean, the numbers in parentheses give the range